Paris-based Aqemia picks up €30 million capital injection to uncover breakthrough drug discoveries at scale
Paris-based Aqemia picks up €30 million capital injection to uncover breakthrough drug discoveries at scale
Pharmatech startup Aqemia has just raised €30 million in a new funding round. The Parisian startup is generating a pioneering drug discovery pipeline that aims to design fast drugs for critical diseases through an AI-powered process that allows drug discovery projects to be scaled like tech projects. One of the core challenges in western medicine… This content is for members only. Visit the site…
View On WordPress










